ArticleHuman vaccines & immunotherapeutics2017

Novel recombinant DNA vaccine candidates for human respiratory syncytial virus: Preclinical evaluation of immunogenicity and protection efficiency.

Mohamed A Farrag et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.